Episode
Healthcare ETFs Compared IYH vs BBH | Business and Finance News
- Published
- Jul 11, 2026
- Duration seconds
- 131
- Processing state
not_requested- Canonical source
- https://sources.thednn.ai/6acbcda38d959edc
Actions
POST https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/healthcare-etfs-compared-iyh-vs-bbh-business-and-finance-news/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/healthcare-etfs-compared-iyh-vs-bbh-business-and-finance-news.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Want to invest in healthcare? Choose between the broad iShares U.S. Healthcare ETF (IYH) or the focused VanEck Biotech ETF (BBH). IYH covers 100 healthcare companies with a solid 1.2% dividend but is heavily weighted toward giants like Eli Lilly and J&J. BBH targets just 25 biotech firms, offering higher growth potential and volatility—with a 33.6% one-year return vs. IYH’s 22.8%, but a steeper 39.9% five-year drawdown. BBH’s lower expense ratio and sensitivity to drug trials make it riskier but more dynamic. Pick IYH for stability and dividends, or BBH if you’re chasing biotech’s explosive upside—and can handle the ride. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/6acbcda38d959edc